$MDAI Cashflow Statement | Understand Stock

$MDAI

$1.53 +$0.03 (2.0%) Close

$MDAI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense
Amortization of debt issuance costs
Stock-based compensation
Amortization of right-of-use assets
Issuance of shares for transaction costs
Change in fair value of warrant liabilities
Transaction costs allocated to warrant liabilities
Interest earned on investments held in Trust Account
Change in fair value of notes payable
Costs from issuance of common stock
Issuance of shares for borrowing related costs
Transaction costs allocated to Avenue Warrants, Investor Warrants, and Hudson Warrants

Changes in operating assets and liabilities:
Accounts receivable
Inventory
Unbilled revenue
Prepaid expenses
Other assets
Accounts payable
Accrued expenses
Accrued offering costs
Income taxes payable
Deferred revenue
Lease liabilities
Net cash used in operating activities
Cash withdrawn from Trust Account to pay franchise and income taxes
Cash withdrawn from Trust Account in connection with redemptions
Investment of cash in Trust Account
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from sale of Units, net of underwriting discounts paid
Proceeds from sale of Private Placements Warrants
Proceeds from issuance of common stock and warrants
Cash received in Business Combination
Payment of issuance costs
Redemptions of common stock
Proceeds from notes payable
Payment of borrowing costs
Proceeds from notes payable - related party
Repayments of promissory note - related party
Payments for notes payable
Proceeds from warrant exercises
Stock option exercises
Net cash provided by financing activities

Effect of exchange rate changes on cash
Net increase in cash
Cash - Beginning of year
Cash - End of year
Cash, beginning of period
Cash, end of period
Supplemental cash flow information:
Cash paid for interest
Cash paid for taxes
Payment of accrued expenses through promissory note
Deferred underwriting fee payable

Noncash investing and financing activities disclosure:
Offering costs included in accrued offering costs
Recognition of Right-of-use assets and related lease liabilities upon adoption of ASC 842
Issuance of common stock for net liabilities upon Business Combination
Prepaid asset acquired, net of cancellation, for debt and accounts payable
Issuance of common stock to settle accounts payable
Recognition of Right-of-use assets and related lease liabilities upon lease amendment
Tenant improvement allowance payments made by the lessor directly to a third party
Issuance of common stock to settle accounts and notes payable
Deferred offering costs included in accrued expenses
Issuance of common stock to settle deferred offering costs
Short-term financing of insurance premium

Comments